Next Article in Journal
The Gut Microbiome in Sepsis: From Dysbiosis to Personalized Therapy
Previous Article in Journal
Targeting KDM1A in Neuroblastoma with NCL-1 Induces a Less Aggressive Phenotype and Suppresses Angiogenesis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Association between Diverticulosis and Colorectal Neoplasia: Analysis from a Large Austrian Database

1
Department of Internal Medicine, General Hospital Oberndorf, Teaching Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria
2
Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, 1090 Vienna, Austria
3
Institute of General Practice, Family Medicine and Preventive Medicine, Paracelsus Medical University, 5020 Salzburg, Austria
4
Department of Internal Medicine, Elisabethinen Hospital Klagenfurt, 9020 Klagenfurt, Austria
5
Clinic I for Internal Medicine, University Hospital Salzburg, Paracelsus Medical University, 5020 Salzburg, Austria
6
Department of Internal Medicine, General Hospital Sankt Vinzenz, 6511 Zams, Austria
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
J. Clin. Med. 2024, 13(20), 6078; https://doi.org/10.3390/jcm13206078
Submission received: 10 September 2024 / Revised: 7 October 2024 / Accepted: 10 October 2024 / Published: 12 October 2024
(This article belongs to the Section Epidemiology & Public Health)

Abstract

:
Background: Colorectal neoplasia and diverticulosis are common findings on colonoscopies. While adenomas are precursors to colorectal cancer, diverticulosis is usually asymptomatic but can lead to diverticulitis. Despite their prevalence and coexistence, the relationship between these conditions remains unclear. This study investigates whether diverticulosis is associated with adenomas, considering shared risk factors and potential inflammation-driven mechanisms. Methods: We examined 6154 asymptomatic individuals undergoing colorectal cancer screening in Austria. Diverticulosis and colorectal neoplasia were documented during screenings based on macroscopic definitions. Advanced neoplasia was defined as polyps >1 cm or high-grade dysplasia. Associations between diverticulosis and neoplastic findings were assessed using univariate and multivariable logistic regression models. Results: Although the overall incidence of any polypoid lesion was higher in the diverticulosis group (37% vs. 30%), statistical analysis revealed a comparable rate of advanced neoplasms in both groups. Importantly, no significant link between diverticulosis and advanced neoplasms was found (OR 1.125; 95% CI: 0.933 to 1.357, p = 0.218) even after adjusting for confounding factors. In a univariate analysis, a statistically significant association between diverticulosis and the presence of any colorectal polyps was identified (OR 1.388; 95% CI: 1.244–1.549, p < 0.0001). However, after adjusting for confounding factors in model 2 (OR 1.065, 95% CI: 0.942 to 1.204, p = 0.314) and model 3 (OR 1.071, 95% CI: 0.925 to 1.239, p = 0.360), this effect was also not statistically significant. Conclusions: Patients with diverticulosis share demographic and clinical features with those at risk of colorectal neoplasia, such as older age, male gender, and higher cardiometabolic risk. However, diverticulosis does not independently increase the risk of advanced colorectal neoplasia or unspecified polypoid lesions.

1. Introduction

The health of the gut encompasses a variety of conditions that can significantly affect an individual’s quality of life in the long term. The occurrence of adenomas and the formation of diverticula are two widespread conditions. Adenomas are benign tumors that have the potential to progress to colorectal cancer if left untreated [1]. With increasing prevalence with age and a higher occurrence in males, around 18% of patients aged 45–50 and 25% of patients aged 50–59 exhibit colonic adenomas [2]. Despite available prevention methods, colorectal cancer is considered a leading cause of cancer morbidity and mortality in developed countries [3].
Diverticulosis refers to usually asymptomatic [4,5] protrusions of the colon mucosa, which can be found in about 30% of individuals under 60 and about 70% of those over 80, [6] often as an incidental finding. Although these diverticula normally do not cause symptoms, about 10–25% of patients eventually develop symptoms. These include symptomatic uncomplicated diverticular disease (SUDD) or, in severe cases, diverticulitis (4%), perforations, and bleeding [7,8,9].
The occurrence of adenomas and diverticulosis is influenced by common risk factors such as age, male gender, metabolic components, dietary habits, and lifestyle [10,11]. Despite the frequency, the mutual relationship is obviously unclear and has been the subject of several controversial studies [12,13,14,15].
This research aims to analyze and investigate an association between diverticulosis and colorectal adenomas or cancer in an asymptomatic Central European CRC screening population, considering common risk and confounding factors as well as the possibility of an inflammation-mediated neoplastic mechanism. To investigate this scientific question, we analyze data from a single-center, epidemiological, retrospective, observational, non-interventional, and uncontrolled cohort study. The study includes participants from the ‘Salzburger Kolon-Karzinom Prävention und Intervention’ (SAKKOPI) project. This research was carried out at the General Hospital Oberndorf, located near Salzburg, Austria, with the focus on colorectal cancer screening, which is recommended in Austria beginning at the age of 45. By analyzing the prevalence, distribution, and potential interrelationship of these conditions, we seek to gain a deeper understanding of their coexistence and their impact on bowel health management.

2. Materials and Methods

2.1. Study Population

Individuals participating in the prospective registry study “Salzburg Colon Cancer Prevention Initiative” (SAKKOPI) were included in this retrospective single-center cohort study. This cohort comprises asymptomatic individuals who underwent colorectal cancer screening at the General Hospital in Oberndorf, Austria, during the period from January 2007 to March 2020. Patients from the general population were enrolled either through referral by their primary care physician or by self-enrollment in an opportunistic screening program, which was fully funded by health insurance, making it free of charge for the participants. The study comprised a total sample size of 6154 participants, all of whom underwent routine screening colonoscopies between one and three times. Each participant provided written informed consent, permitting the use of their data for scientific research purposes.
Clinical and laboratory data were collected for all participants, who also completed a medical history questionnaire. We defined and calculated body mass index (BMI), arterial hypertension, smoking status, dyslipidemia, and metabolic syndrome in accordance with current guidelines [16,17,18]. All patients from the study cohort who had valid data relevant to the research question, particularly regarding the presence of colonic diverticulosis, were included in our analysis. The process of patient enrollment is illustrated in Figure 1. This cohort has already been extensively described in previous studies [19].

2.2. Patient Assessment for Risk Factors

All patients were examined over a period of 2 consecutive days. On the first day, upon hospital admission, their vital signs were recorded, clinical assessments were performed, and laboratory tests were conducted: To gather the necessary data, a comprehensive medical history was obtained through an interview process (clinical history). This anamnesis, along with the results of the physical examination, was recorded in the medical software (Patidok 2.0, Professional Clinical Software GmbH, Klagenfurt, Austria). Vital signs were measured using certified blood pressure monitors and pulse oximeters, with the digital data entered into the system. Electrocardiogram (ECG) results were directly imported from certified devices into the medical software for further medical evaluation. Height, weight, and measurements of waist and hip circumference were input into the system by trained nursing staff, with the BMI automatically calculated afterward. Research staff then manually extracted the required data from the digitized medical records and anonymously transferred it into a database (Microsoft Access 16.0, Microsoft, Redmond, WA, USA). Additional data were collected through a paper-based questionnaire, which included dichotomous questions, group categories, rating scales with graded responses, as well as single- and multiple-choice options with supplemental selections. The questionnaire gathered further information on diet, physical activity, and social factors. Numerical data on dietary habits and physical activity were also collected. Patients provided details about their family and medical history via the questionnaire. In instances where there were uncertainties or missing information in the questionnaire or clinical history, participants were contacted by phone or mail for clarification. Blood samples were mostly analyzed in the hospital’s internal laboratory. The laboratory tests covered routine parameters such as complete blood count, electrolytes, liver and kidney function, pancreatic enzymes, inflammation markers, lipids, blood coagulation, iron and copper metabolism, erythrocyte sedimentation rate, protein electrophoresis, and glucose metabolism markers (including insulin levels, HbA1c, and oral glucose tolerance test). Each participant underwent a standardized abdominal ultrasound and a FibroScan, which included the Controlled Attenuation Parameter (CAP) and elasticity median to assess liver fibrosis and steatosis. The second day was dedicated to performing colonoscopies. All colonoscopies were carried out by default by experienced endoscopists. Patients were sedated using Propofol or a combination of Propofol and Midazolam. Body mass index (BMI) was calculated based on World Health Organization (WHO) standards, and arterial hypertension was categorized according to the European Society of Cardiology (ESC) guidelines on blood pressure control [17]. The classification of smoking behavior was divided into “never smokers” and “active smokers” based on participant-reported information. Metabolic syndrome was defined according to the criteria set forth by the IDF/AHA/NHLBI consensus [18]. Additionally, a family history of colorectal carcinoma (CRC) was evaluated, and patients were classified as having a positive family history if they had a first-degree relative (parent, sibling, or child) diagnosed with CRC.

2.3. Assessment of Colorectal Lesions and Diverticulosis

The colonoscopy procedure followed international guidelines, ensuring that all established performance standards were achieved [20]. Based on the findings, patients were classified into one of the following groups: “no diverticulosis”, “left-sided diverticulosis”, “right-sided diverticulosis”, or “pandiverticulosis”. All polyps underwent histopathologic examination and were classified according to their macroscopic and microscopic characteristics. Advanced colorectal neoplasia was defined as an adenoma measuring ≥1 cm, exhibiting high-grade dysplasia or villous features, or as histologically confirmed colorectal carcinoma [21]. The category of any polypoid lesion encompasses hyperplastic polyps, adenoma, advanced neoplasms, serrated lesions, and carcinoma.

2.4. Statistical Analysis

Continuous data were evaluated using either the Mann–Whitney U test or the Student’s t test, based on the data distribution. The findings are reported as median  ±  interquartile range (IQR) or mean  ±  standard deviation (SD), respectively. Categorical data are presented as frequencies (percentages) and were analyzed with the chi-square test. All statistical tests were two-tailed, and a p-value of less than 0.05 was deemed significant. The primary endpoint was advanced neoplasia presence, with the secondary endpoint focusing on any polyp detection identified during screening colonoscopy. The definition of advanced colorectal neoplasia was as previously established [21]. The primary exposure was the presence or absence of diverticula, and the primary endpoint was advanced colorectal neoplasia. The secondary endpoint was any macroscopic polypoid lesion. Model 1 represents the univariate analysis. We performed a multivariable logistic regression, adjusting for age, sex, metabolic syndrome, and educational level (model 2), and additionally for alcohol consumption, red meat intake, fast food consumption, vegetable and fruit intake, and physical activity (Model 3). We further conducted sensitivity analyses for sex, age (above and below 55 years), obesity (BMI > 30), and the presence of metabolic syndrome using model 1. The odds ratios (ORs) with their 95% confidence intervals (CIs) were derived for the dichotomous outcome variables. Statistical evaluations were carried out with StataNow version 18.5 (StataCorp LLC, College Station, TX, USA).

3. Results

In this study involving 6154 individuals, significant differences were observed based on the presence of diverticulosis, particularly regarding age, gender and the prevalence of metabolic syndrome. In our study population, the median age of patients without diverticulosis is 56 years (IQR: 51–63), while for those with diverticulosis, the median age is significantly higher at 62 years (IQR: 55–69 years). When further stratified by age groups, it becomes clear that younger patients are less likely to have diverticulosis. For instance, only 2% of patients with diverticulosis are under 45 years old, compared to 8% in the non-diverticulosis group. A similar pattern is observed in the 45–54 age group. The distribution becomes more balanced in the 55–64 age group. However, among patients with diverticulosis, 32% fall within the 65–74 age range, while only 17% of those without diverticulosis are in this age group. This upward trend continues in the oldest age group, highlighting a strong correlation between advancing age and the likelihood of developing diverticulosis (Figure 2).
This trend is particularly noteworthy given the parallel increase in the incidence of colorectal neoplasia with advancing age, underscoring the importance of investigating the potential independent association between diverticulosis and colorectal neoplasia.
In the group without diverticulosis (N = 3877), females accounted for 50% (1930) of the population, whereas in the diverticulosis group (N = 2277), they comprised only 44% (1009), highlighting a significant gender disparity (p < 0.001). This finding suggests a potential male predominance in the occurrence of diverticulosis. Moreover, metabolic syndrome was more prevalent in individuals with diverticulosis, affecting 84% (1906), versus 73% (2836) of those without (p < 0.001) (Table 1).
Overall, 9% (197 individuals) with diverticulosis and 8% (301 individuals) without diverticulosis had advanced neoplasia (Figure 3).
Specifically, the OR for advanced lesions in individuals with diverticulosis was 1.125 (95% CI: 0.933 to 1.357, p = 0.218), suggesting no significant link between diverticulosis and advanced neoplasias. Furthermore, the multivariable analysis in model 2 that adjusted for age, sex, metabolic syndrome, and education level (OR 0.844, 95% CI: 0.688 to 1.037, p = 0.106) and in model 3 that additionally adjusted for alcohol consumption, red meat intake, fast food consumption, vegetable and fruit intake, and physical activity (OR 0.797, 95% CI: 0.626 to 1.016, p = 0.067) reinforced the lack of a significant association. The sensitivity analysis performed also showed no evidence of an association between diverticulosis and advanced neoplasia (Table 2).
Regarding the occurrence of “any polypoid lesion”, 37% (844 individuals) of the diverticulosis group and 30% (1156 individuals) of the group without diverticulosis were affected (Figure 3). In the univariate analysis, a statistically significant association between diverticulosis and the presence of any polyp was identified, with an odds ratio of 1.388 (95% CI: 1.244 to 1.549, p < 0.0001), indicating that individuals with diverticulosis were more likely to have a polyp. This was also confirmed in the conducted sensitivity analysis (Table 3).
However, this association was not observed in the multivariable analysis after adjusting for confounding factors in model 2 (OR 1.065, 95% CI: 0.942 to 1.204, p = 0.314) and in model 3 (OR 1.071, 95% CI: 0.925 to 1.239, p = 0.360), suggesting that the association seen in the univariate analysis might be influenced by these confounders.

4. Discussion

In recent decades, several studies have examined the relationship between diverticulosis and colorectal polyps. However, these studies are very heterogeneous due to different study designs, differently defined patient groups and indications for colonoscopy, as well as various ethnicities. A review of this topic seems particularly useful in terms of the clinical relevance of a potentially more intensive early detection program when associating these two common local findings for cancer prevention.
The results of our study significantly contribute to the literature regarding the relationship between diverticulosis and colorectal neoplasms in an asymptomatic screening population. While our study showed an increased overall incidence of any polypoid lesions in the diverticulosis group, logistic regression analysis revealed that the rate of advanced neoplasms was comparable between the groups. Even though the univariate analysis showed a statistically significant association between diverticulosis and the presence of any polyps, no association could be determined after adjusting for confounding factors such as age, gender, metabolic syndrome, and education in model 2 or additionally for alcohol consumption, red meat intake, fast food consumption, vegetable and fruit intake, and physical activity in model 3. This suggests that the association observed in the univariate analysis is influenced by these confounding factors.
Similar to our results, the prospective data collected by Poszler A. et al. from two centers in Germany show that after accounting for possible confounding factors (gender, age, diabetes, BMI, alcohol or nicotine abuse, indication for colonoscopy, withdrawal time), colonic diverticulosis was no longer significantly associated with the detection of adenomas [22].
As the study rightly points out, the study data concerning patients of Asian descent should be critically examined, such as the data from Hong W et al., where no statistically significant association between diverticulosis and adenomas or advanced adenomas could be established. This is because this study population showed significantly fewer cases of left-sided diverticulosis, which is more common in Western populations [13].
A comprehensive meta-analysis by Lee HJ et al., which included 29 cross-sectional studies and 450,953 patients, also showed no association between the occurrence of diverticulosis and advanced adenomas. However, regarding the overall rate of adenomas, there was an increase observed in patients with diverticulosis who exhibited gastrointestinal symptoms and did not undergo colonoscopy purely for CRC (colorectal cancer) screening purposes. These results suggest that the indication of colonoscopy could influence the rate of adenoma detection. Additionally, the described association was particularly evident in published studies, whereas unpublished data showed no such correlation [12]. Even though measures to avoid publication bias were taken by the authors, this must be considered overall. It should also be noted that there was no valid information available on the quality of adenoma detection or colonoscopy, and there are limitations regarding relevant confounding factors and their statistical correction.
A meta-analysis of 14 observational studies by Jaruvongvanich V et al. yielded contradictory results, showing that diverticulosis was associated with an increased risk of colorectal adenomas, but not with advanced colorectal adenomas and colorectal cancer [15]. Due to the statistical heterogeneity in different study designs, a lack of subgroup analysis and correction for confounding factors, as well as suspected publication bias, the association between diverticulosis and colon adenomas should be interpreted with caution.
It is strikingly evident that in studies with a positive association, such as those by Valvano M et al. [23] and Viscido A et al. [24], the indications of colonoscopy significantly differ from those without a statistically significant correlation, as previously mentioned. In the study by Valvano M et al., patients with a positive Hemoccult test, family history, or previous polypectomy were examined [23]. In the study by Viscido A et al., the examination was conducted due to lower abdominal pain or discomfort, hematochezia, changes in bowel habits, weight loss, iron deficiency anemia, chronic constipation, chronic diarrhea, and follow-up after colon polypectomy [24].
This reinforces the theory that the indication of a colonoscopy influences the adenoma detection rate, and therefore the hypothesized association should be critically examined. The data presented by Rondagh EJA et al., which describe a statistically significant correlation between adenomas, advanced adenomas, and diverticulosis in patients under 60 years old, are also based on a mixed patient cohort consisting of symptomatic patients, surveillance, and screening colonoscopies [14].
According to our results, there is currently no established common pathophysiological mechanism known to be responsible for the formation of both adenomas and diverticula. While dysplastic processes at the mucosal level are significantly responsible for the formation of adenomas [25], structural changes affecting the connective tissue, smooth muscle [26], and blood vessels [27,28] of the intestinal wall are likely associated with the formation of diverticula. Conversely, chronic inflammatory processes of the mucosa, which can also be detected microscopically in asymptomatic diverticulosis patients between the formed diverticula, could potentially promote the formation of adenomas [29].
Strengths of this analysis include its large number of participants and the comprehensive adjustment for potential confounding factors. However, there are also limitations concerning the study. The cross-sectional approach of our study captures the variables of interest at a single moment, offering only a limited view of the situation at that particular time. As a result, causal links cannot be established and shifts or trends over time cannot be evaluated. Because of the cross-sectional design, there is a potential for confounding variables that may not be entirely accounted for or controlled. Furthermore, in the asymptomatic screening population studied, the presence of selection and information biases, potentially influenced by factors such as general health awareness and public health outreach efforts, could affect the robustness of the findings. These biases may lead to an overrepresentation of individuals who are more health-conscious or have greater access to healthcare resources, thereby limiting the generalizability of the results to the broader population. Selecting a single center as the study location restricts the ability to generalize our findings to other geographic regions or population groups. Regional factors and patient profiles might be unique to the selected center and therefore may not accurately reflect the broader population of Western society. Additionally, the risk of a type II error cannot be excluded, meaning that some associations may have been missed due to insufficient power to detect smaller effect sizes. Because our study does not cover fundamental scientific elements, a detailed investigation at the cellular or molecular level is lacking.
Future research should focus on prospective studies that illuminate the causal relationships and underlying mechanisms between diverticulosis and colorectal neoplasms. This includes conducting long-term studies to assess the progression of diverticulosis and its potential impact on the development of colorectal cancer over time, clarifying whether changes in diverticulosis status correlate with shifts in neoplastic findings. Additionally, investigating specific biomarkers that may indicate inflammatory or neoplastic processes in patients with diverticulosis could help identify individuals at higher risk of neoplasia. Furthermore, further basic research at the cellular or molecular level is essential for a deeper understanding of these conditions.

5. Conclusions

In summary, our study revealed that patients with diverticulosis exhibit demographic and clinical features commonly associated with colorectal neoplasia, such as older age, male gender, and a higher prevalence of cardiometabolic risk factors. Importantly, the occurrence of adenomas in patients with diverticulosis appears to be incidental and bears no direct relationship to diverticulosis, as adenomas are common in the general population. While diverticulosis shares risk factors with colorectal neoplasia, our findings suggest that diverticulosis itself does not independently increase the risk of advanced colorectal neoplasia or unspecified polypoid lesions.

Author Contributions

A.V. and B.W. conceived the research project. L.D. helped to collect and organize the raw data. B.W. conducted the statistical analysis. A.V. wrote the first draft of the manuscript. B.W., S.W., G.S., H.H., N.G., M.A., M.F., E.A. and C.D. provided critical feedback and improved the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

We performed the study and all procedures according to the principles of the Declaration of Helsinki. The local ethics committee for the province of Salzburg approved the study protocol (approval no. 415-E/1262—29 September 2010). Written informed consent was obtained from every participant.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available on request from the corresponding author due to ethical considerations and privacy concerns.

Conflicts of Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. However, the following author discloses a conflict of interests outside of the submitted work: C.D. is part of the scientific advisory board of SPAR Österreich AG.

References

  1. Fearon, E.R.; Vogelstein, B. A Genetic Model for Colorectal Tumorigenesis. Cell 1990, 61, 759–767. [Google Scholar] [CrossRef] [PubMed]
  2. Kolb, J.M.; Hu, J.; DeSanto, K.; Gao, D.; Singh, S.; Imperiale, T.; Lieberman, D.A.; Boland, C.R.; Patel, S.G. Early-Age Onset Colorectal Neoplasia in Average-Risk Individuals Undergoing Screening Colonoscopy: A Systematic Review and Meta-Analysis. Gastroenterology 2021, 161, 1145–1155.e12. [Google Scholar] [CrossRef] [PubMed]
  3. GBD 2013 Mortality and Causes of Death Collaborators Global, Regional, and National Age-Sex Specific All-Cause and Cause-Specific Mortality for 240 Causes of Death, 1990–2013: A Systematic Analysis for the Global Burden of Disease Study 2013. Lancet 2015, 385, 117–171. [CrossRef] [PubMed]
  4. Schultz, J.K.; Azhar, N.; Binda, G.A.; Barbara, G.; Biondo, S.; Boermeester, M.A.; Chabok, A.; Consten, E.C.J.; van Dijk, S.T.; Johanssen, A.; et al. European Society of Coloproctology: Guidelines for the Management of Diverticular Disease of the Colon. Color. Dis. 2020, 22 (Suppl. S2), 5–28. [Google Scholar] [CrossRef] [PubMed]
  5. Tursi, A.; Scarpignato, C.; Strate, L.L.; Lanas, A.; Kruis, W.; Lahat, A.; Danese, S. Colonic Diverticular Disease. Nat. Rev. Dis. Primers 2020, 6, 20. [Google Scholar] [CrossRef]
  6. Everhart, J.E.; Ruhl, C.E. Burden of Digestive Diseases in the United States Part II: Lower Gastrointestinal Diseases. Gastroenterology 2009, 136, 741–754. [Google Scholar] [CrossRef]
  7. Peery, A.F.; Shaukat, A.; Strate, L.L. AGA Clinical Practice Update on Medical Management of Colonic Diverticulitis: Expert Review. Gastroenterology 2021, 160, 906–911.e1. [Google Scholar] [CrossRef]
  8. Shahedi, K.; Fuller, G.; Bolus, R.; Cohen, E.; Vu, M.; Shah, R.; Agarwal, N.; Kaneshiro, M.; Atia, M.; Sheen, V.; et al. Long-Term Risk of Acute Diverticulitis among Patients with Incidental Diverticulosis Found during Colonoscopy. Clin. Gastroenterol. Hepatol. 2013, 11, 1609–1613. [Google Scholar] [CrossRef]
  9. Stollman, N.; Smalley, W.; Hirano, I. AGA Institute Clinical Guidelines Committee American Gastroenterological Association Institute Guideline on the Management of Acute Diverticulitis. Gastroenterology 2015, 149, 1944–1949. [Google Scholar] [CrossRef]
  10. Sninsky, J.A.; Shore, B.M.; Lupu, G.V.; Crockett, S.D. Risk Factors for Colorectal Polyps and Cancer. Gastrointest. Endosc. Clin. N. Am. 2022, 32, 195–213. [Google Scholar] [CrossRef]
  11. Völkerer, A.; Wernly, S.; Semmler, G.; Flamm, M.; Aigner, E.; Datz, C.; Wernly, B. Diverticulosis and Cardiometabolic Risk Factors: A Systematic Literature Review. Int. J. Colorectal Dis. 2023, 38, 236. [Google Scholar] [CrossRef] [PubMed]
  12. Lee, H.J.; Park, S.J.; Cheon, J.H.; Kim, T.I.; Kim, W.H.; Kim, H.J. The Relationship between Diverticulosis and Colorectal Neoplasia: A Meta-Analysis. PLoS ONE 2019, 14, e0216380. [Google Scholar] [CrossRef] [PubMed]
  13. Hong, W.; Dong, L.; Zippi, M.; Stock, S.; Geng, W.; Xu, C.; Zhou, M. Colonic Diverticulosis Is Not a Risk Factor for Colonic Adenoma. Ther. Clin. Risk Manag. 2018, 14, 531–537. [Google Scholar] [CrossRef]
  14. Rondagh, E.J.A.; Sanduleanu, S.; le Clercq, C.M.C.; Winkens, B.; Masclee, A.A.M. Diverticulosis and Colorectal Polyps at Younger Age: A Possible Link? Eur. J. Gastroenterol. Hepatol. 2011, 23, 1050–1055. [Google Scholar] [CrossRef]
  15. Jaruvongvanich, V.; Sanguankeo, A.; Wijarnpreecha, K.; Upala, S. Risk of Colorectal Adenomas, Advanced Adenomas and Cancer in Patients with Colonic Diverticular Disease: Systematic Review and Meta-Analysis. Dig. Endosc. 2017, 29, 73–82. [Google Scholar] [CrossRef]
  16. Alberti, K.G.M.M.; Zimmet, P.; Shaw, J. IDF Epidemiology Task Force Consensus Group The Metabolic Syndrome—A New Worldwide Definition. Lancet 2005, 366, 1059–1062. [Google Scholar] [CrossRef]
  17. Williams, B.; Mancia, G.; Spiering, W.; Rosei, A.; Azizi, M.; Burnier, M.; Clement, D.L.; Coca, A.; Dominiczak, A.; Kahan, T.; et al. 2018 ESC/ESH Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur. Heart J. 2018, 39, 3021–3104. [Google Scholar] [CrossRef] [PubMed]
  18. Alberti, K.G.M.M.; Eckel, R.H.; Grundy, S.M.; Zimmet, P.Z.; Cleeman, J.I.; Donato, K.A.; Fruchart, J.-C.; James, W.P.T.; Loria, C.M.; Smith, S.C., Jr.; et al. Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120, 1640–1645. [Google Scholar]
  19. Wernly, S.; Wernly, B.; Semmler, G.; Bachmayer, S.; Niederseer, D.; Stickel, F.; Huber-Schönauer, U.; Aigner, E.; Datz, C. A Sex-Specific Propensity-Adjusted Analysis of Colonic Adenoma Detection Rates in a Screening Cohort. Sci. Rep. 2021, 11, 17785. [Google Scholar] [CrossRef]
  20. Bisschops, R.; Areia, M.; Coron, E.; Dobru, D.; Kaskas, B.; Kuvaev, R.; Pech, O.; Ragunath, K.; Weusten, B.; Familiari, P.; et al. Performance Measures for Upper Gastrointestinal Endoscopy: A European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy 2016, 48, 843–864. [Google Scholar] [CrossRef]
  21. Semmler, G.; Wernly, S.; Wernly, B.; Mamandipoor, B.; Bachmayer, S.; Semmler, L.; Aigner, E.; Datz, C.; Osmani, V. Machine Learning Models Cannot Replace Screening Colonoscopy for the Prediction of Advanced Colorectal Adenoma. J. Pers. Med. 2021, 11, 981. [Google Scholar] [CrossRef] [PubMed]
  22. Poszler, A.; Walter, B.; Aulehner-Forlenza, C.; Haller, B.; Abdelhafez, M.; Brown, H.; von Delius, S.; Born, P.; Schmid, R.M.; Bajbouj, M.; et al. Colon Diverticulosis Is Not a Risk Factor for the Detection of Adenomatous Polyps—Results of a Prospective Study. Z. Gastroenterol. 2021, 59, 135–142. [Google Scholar] [CrossRef] [PubMed]
  23. Valvano, M.; Vezzaro, V.; Fabiani, S.; Capannolo, A.; Sgamma, E.; Cesaro, N.; Valerii, G.; Longo, S.; Barbera, C.; Lombardi, L.; et al. The Connection between Diverticulosis and Colonic Superficial Neoplastic Lesions in Patients Who Underwent Screening Colonoscopy. Int. J. Colorectal Dis. 2023, 38, 107. [Google Scholar] [CrossRef] [PubMed]
  24. Viscido, A.; Ciccone, F.; Vernia, F.; Gabrieli, D.; Capannolo, A.; Stefanelli, G.; Necozione, S.; Valerii, G.; Ashktorab, H.; Latella, G. Association of Colonic Diverticula with Colorectal Adenomas and Cancer. Medicina 2021, 57, 108. [Google Scholar] [CrossRef] [PubMed]
  25. Testa, U.; Pelosi, E.; Castelli, G. Colorectal Cancer: Genetic Abnormalities, Tumor Progression, Tumor Heterogeneity, Clonal Evolution and Tumor-Initiating Cells. Med. Sci. 2018, 6, 31. [Google Scholar] [CrossRef]
  26. Spiller, R.C. Changing Views on Diverticular Disease: Impact of Aging, Obesity, Diet, and Microbiota. Neurogastroenterol. Motil. 2015, 27, 305–312. [Google Scholar] [CrossRef]
  27. Xiao, L.; Harrison, D.G. Inflammation in Hypertension. Can. J. Cardiol. 2020, 36, 635–647. [Google Scholar] [CrossRef]
  28. Csiszar, A.; Labinskyy, N.; Smith, K.; Rivera, A.; Orosz, Z.; Ungvari, Z. Vasculoprotective Effects of Anti-Tumor Necrosis Factor-Alpha Treatment in Aging. Am. J. Pathol. 2007, 170, 388–398. [Google Scholar] [CrossRef]
  29. Tursi, A.; Brandimarte, G.; Elisei, W.; Giorgetti, G.M.; Inchingolo, C.D.; Danese, S.; Aiello, F. Assessment and Grading of Mucosal Inflammation in Colonic Diverticular Disease. J. Clin. Gastroenterol. 2008, 42, 699–703. [Google Scholar] [CrossRef]
Figure 1. Flow diagram of patient enrollment.
Figure 1. Flow diagram of patient enrollment.
Jcm 13 06078 g001
Figure 2. Percentage distribution of age groups among patients with and without diverticulosis.
Figure 2. Percentage distribution of age groups among patients with and without diverticulosis.
Jcm 13 06078 g002
Figure 3. Adenoma rates in the corresponding diverticulosis category.
Figure 3. Adenoma rates in the corresponding diverticulosis category.
Jcm 13 06078 g003
Table 1. Baseline characteristics of patients with and without diverticulosis. (BMI: Body Mass Index; HGB: Hemoglobin; MCV: Mean Corpuscular Volume; CRP: C-reactive protein).
Table 1. Baseline characteristics of patients with and without diverticulosis. (BMI: Body Mass Index; HGB: Hemoglobin; MCV: Mean Corpuscular Volume; CRP: C-reactive protein).
No DiverticulosisDiverticulosisp-Value
N = 3877N = 2277
AGE56 (51–63)62 (55–69)<0.001
Age < 45 years8% (298)2% (39)
Age 45–54 years38% (1457)20% (465)
Age 55–64 years34% (1321)36% (824)
Age 65–74 years17% (642)32% (723)
Age ≥ 75 years4% (159)10% (226)
SEX <0.001
Female50% (1930)44% (1009)
Male50% (1947)56% (1268)
BMI26 (23–29)28 (25–30)<0.001
Underweight1% (39)0% (6)
Normal weight40% (1534)26% (582)
Pre-obesity39% (1529)45% (1021)
Obesity20% (775)29% (668)
Hypertension52% (2035)67% (1523)<0.001
Diabetes16% (607)20% (454)<0.001
HbA1c5.5 (5.2–5.7)5.6 (5.3–5.8)<0.001
Metabolic syndrome73% (2836)84% (1906)<0.001
Creatinine0.9 (0.8–1.0)0.9 (0.8–1.0)0.06
HGB14.6 (13.7–15.4)14.7 (13.9–15.5)<0.001
MCV87 (85–90)87 (84–90)0.38
Thrombocytes232 (200–271)226 (193–264)<0.001
Leukocytes5.7 (4.9–6.7)5.9 (5.0–7.2)<0.001
CRP0.2 (0.1–0.3)0.2 (0.1–0.4)<0.001
ADENOMA <0.001
No Adenoma71% (2738)63% (1438)
One adenoma18% (693)22% (494)
Two adenomas6% (244)8% (192)
Three adenomas3% (117)4% (88)
Four adenomas1% (40)1% (33)
Five adenomas1% (20)1% (18)
Six adenomas0% (11)0% (4)
Table 2. Sensitivity analyses for sex, age, obesity (BMI > 30), and metabolic syndrome of advanced neoplasia and diverticulosis.
Table 2. Sensitivity analyses for sex, age, obesity (BMI > 30), and metabolic syndrome of advanced neoplasia and diverticulosis.
Advanced Adenoma
SubgroupORCI 95%p-Value
SEX
Male0.9820.781–1.2360.881
Female1.3310.956–1.8510.09
METABOLIC SYNDROME
Yes1.0780.88–1.3220.465
No1.0680.644–1.7720.798
AGE
≤55 a1.1590.747–1.800.51
>55 a0.8970.726–1.1080.313
BMI
<301.2270.984–1.5290.069
≥300.8450.59–1.210.357
Table 3. Sensitivity analyses for sex, age, obesity (BMI > 30), and metabolic syndrome of any polypoid lesion and diverticulosis.
Table 3. Sensitivity analyses for sex, age, obesity (BMI > 30), and metabolic syndrome of any polypoid lesion and diverticulosis.
Any Polypoid Lesion
SubgroupORCI 95%p-Value
SEX
Male1.2841.111–1.4830.001
Female1.4511.223–1.723<0.001
METABOLIC SYNDROME
Yes1.2601.116–1.422<0.001
No1.6521.264–2.158<0.001
AGE
≤55 a1.2941.038–1.6150.022
>55 a1.1411.000–1.3010.05
BMI
<301.4011.232–1.593<0.001
≥301.2551.013–1.5540.037
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Völkerer, A.; Wernly, S.; Semmler, G.; Flamm, M.; Ausserwinkler, M.; Datz, L.; Götz, N.; Hofer, H.; Aigner, E.; Datz, C.; et al. Association between Diverticulosis and Colorectal Neoplasia: Analysis from a Large Austrian Database. J. Clin. Med. 2024, 13, 6078. https://doi.org/10.3390/jcm13206078

AMA Style

Völkerer A, Wernly S, Semmler G, Flamm M, Ausserwinkler M, Datz L, Götz N, Hofer H, Aigner E, Datz C, et al. Association between Diverticulosis and Colorectal Neoplasia: Analysis from a Large Austrian Database. Journal of Clinical Medicine. 2024; 13(20):6078. https://doi.org/10.3390/jcm13206078

Chicago/Turabian Style

Völkerer, Andreas, Sarah Wernly, Georg Semmler, Maria Flamm, Mathias Ausserwinkler, Leonora Datz, Nikolaus Götz, Hannah Hofer, Elmar Aigner, Christian Datz, and et al. 2024. "Association between Diverticulosis and Colorectal Neoplasia: Analysis from a Large Austrian Database" Journal of Clinical Medicine 13, no. 20: 6078. https://doi.org/10.3390/jcm13206078

APA Style

Völkerer, A., Wernly, S., Semmler, G., Flamm, M., Ausserwinkler, M., Datz, L., Götz, N., Hofer, H., Aigner, E., Datz, C., & Wernly, B. (2024). Association between Diverticulosis and Colorectal Neoplasia: Analysis from a Large Austrian Database. Journal of Clinical Medicine, 13(20), 6078. https://doi.org/10.3390/jcm13206078

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop